Search hospitals > California > Los Angeles
University of Southern California
Claim this profileLos Angeles, California 90033
Global Leader in Cancer
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Alzheimer's Disease
Conducts research for Tumors
Conducts research for Stroke
660 reported clinical trials
61 medical researchers
Summary
University of Southern California is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Human Immunodeficiency Virus Infection, Alzheimer's Disease, Tumors, Stroke and other specialties. University of Southern California is involved with conducting 660 clinical trials across 715 conditions. There are 61 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, Jorge J. Nieva, and Jacob Thomas, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Human Immunodeficiency Virus Infection
Global LeaderHIV infection positive
Top PIs
Anthony El-Khoueiry, MDUSC Norris Comprehensive Cancer Center1 year of reported clinical research
Expert in Tumors
Expert in Solid Tumors
35 reported clinical trials
52 drugs studied
Heinz-Josef LenzUSC / Norris Comprehensive Cancer Center6 years of reported clinical research
Expert in Colorectal Cancer
Expert in Adenocarcinoma
33 reported clinical trials
61 drugs studied
Jorge J. NievaUSC / Norris Comprehensive Cancer Center4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
27 drugs studied
Jacob Thomas, MDUSC Norris Comprehensive Cancer Center1 year of reported clinical research
Studies Squamous Cell Carcinoma
Studies Cancer
22 reported clinical trials
32 drugs studied
Clinical Trials running at University of Southern California
Tumors
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Cancer
Cervical Cancer
Depression
Solid Tumors
Lymphoma
Stroke
Cutaneous T-Cell Lymphoma
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
Utidelone Capsules
for Advanced Cancer
The purpose of this trial is to evaluate the safety and tolerability of Utidelone Capsule in patients with advanced solid tumors and determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT). The secondary objectives are to evaluate the pharmacokinetic profile of Utidelone Capsule in patients with advanced solid tumors, preliminarily assess the anti-tumor activity of Utidelone Capsule in patients with advanced solid tumors via objective radiologic tumor response using RECIST 1.1, and to recommend the dose and dosage regimen for subsequent clinical trials.
Recruiting1 award Phase 1
NX-1607
for Advanced Cancer
This trial is testing NX-1607, a new experimental drug, in adults with advanced cancers that don't respond to standard treatments. The goal is to see if NX-1607 can safely stop or reduce cancer growth, either by itself or with another drug called paclitaxel. Paclitaxel is a widely used anti-cancer drug for treating various types of solid malignant tumors including breast, ovarian, and lung cancers.
Recruiting1 award Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Southern California?
University of Southern California is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Human Immunodeficiency Virus Infection, Alzheimer's Disease, Tumors, Stroke and other specialties. University of Southern California is involved with conducting 660 clinical trials across 715 conditions. There are 61 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, Jorge J. Nieva, and Jacob Thomas, MD.
Where is University of Southern California located?
The University of Southern California (USC) Hospital, situated at 1500 San Pablo St, Los Angeles, California, is a key component of the Keck Medical Center of USC, encompassing both the Keck Hospital of USC and the USC Norris Cancer Hospital. It provides a wide range of services including dermatology, clinical nutrition, breast cancer care, and critical care medicine. Parking options include the Keck parking structure accessible from San Pablo Street, metered parking on Jefferson Boulevard, and the Jefferson Boulevard Parking Structure offering a $14 daily fee.
Who should I call to ask about financial aid or insurance network?
**University of Southern California (USC) Hospitals Financial Assistance:**
- **Patient Financial Services Department:** For assistance, call 626-574-3594 (available 8 a.m. - 4:30 p.m.).
- **USC Financial Aid Office:** For general inquiries, call (213) 740-4444 or visit the USC Financial Aid website.
- **Student Health Insurance/Billing:** Contact the Student Health Insurance Office at 213-821-1550 or 213-740-9355 (WELL).
- **USC Health Plans:** For information, call (213) 740-0035 or email healthplans@usc.edu.
What insurance does University of Southern California accept?
The University of Southern California (USC) offers comprehensive insurance options:
- USC PPO includes three coverage tiers: Keck Medicine of USC providers, nationwide and worldwide Anthem providers, and non-network provider coverage.
- USC Arcadia Hospital accepts most health care insurance plans. For details, contact Patient Financial Services.
- USC Senior Care, a supplemental Medicare plan for University retirees, allows access to any doctor nationwide that accepts Medicare, with special benefits for services from Keck Medicine of USC physicians and affiliated hospitals.
- USC mandates health insurance for all students, providing the USC SHIP/Aetna plan with vision care through EyeMed and a separate dental plan.
UCLA Health accepts Medicare, most HMO, and PPO insurance plans.
What awards or recognition has University of Southern California received?
The University of Southern California (USC) and Children's Hospital Los Angeles (CHLA) have been awarded a $40 million gift from the Alfred E. Mann Charities. This generous donation will enhance research and innovation in biomedical engineering, supporting education, scholarships, and the creation of medical inventions at the USC Alfred E. Mann Institute. Furthermore, the establishment of the USC Alfred E. Mann-CHLA Joint Research Fund aims to advance biomedical research and innovation, specifically targeting improvements in pediatric care.